Trading Signals: CRSP Stock Price Prediction and Forecast (Wed. Oct. 19, 2016 - Fri. Dec. 22, 2023)(CRISPR Therapeutics AG)
| CRSP latest price $49.0400 (-1.37%) ($48.5800 - $50.0000) on Sat. Jul. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.41% (three month average) | RSI | 62 | Latest Price | $49.0400(-1.37%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CRSP advances 1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CRSP advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CRSP price | CRSP will decline at least -1.705% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.705% (StdDev 3.41%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $49.16(-0.24%) | 10 Day Moving Average | $48.95(0.18%) | 20 Day Moving Average | $47.53(3.18%) | To recent high | -1.6% | To recent low | 37.9% | Market Cap | $N/A | | | | CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland. |